Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Buy now fake rolex


First new therapy nod in 20yrs

Posted 15 September 2021 AM

Australian patients with an aggressive form of lung cancer have access to a new treatment after the TGA approved Zepzelca - the first new therapy ticked to treat second-line metastatic small cell lung cancer (SCLC) in more than two decades.

Specialised Therapeutics (ST) announced the approval which was fast tracked via Project Orbis, for the treatment of patients with metastatic SCLC that has progressed on or after prior platinum-containing therapy.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Melb pharma registers first copy
Long list of generic versions of PBS-listed drugs